Please use this identifier to cite or link to this item: https://dspace.iiti.ac.in/handle/123456789/10562
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKashyap, Dharmendraen_US
dc.contributor.authorRoy, Rajarshien_US
dc.contributor.authorKar, Parimalen_US
dc.contributor.authorJha, Hem Chandraen_US
dc.date.accessioned2022-07-15T10:45:55Z-
dc.date.available2022-07-15T10:45:55Z-
dc.date.issued2022-
dc.identifier.citationKashyap, D., Roy, R., Kar, P., & Jha, H. C. (2022). Plant-derived active compounds as a potential nucleocapsid protein inhibitor of SARS-CoV-2: An in-silico study. Journal of Biomolecular Structure and Dynamics, 1–16. https://doi.org/10.1080/07391102.2022.2072951en_US
dc.identifier.issn0739-1102-
dc.identifier.otherEID(2-s2.0-85130102854)-
dc.identifier.urihttps://doi.org/10.1080/07391102.2022.2072951-
dc.identifier.urihttps://dspace.iiti.ac.in/handle/123456789/10562-
dc.description.abstractThe coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2. This virus has a high mismatch repair proofreading ability due to its unique exonuclease activity, making it knotty to treat. The nucleocapsid protein can serve as a potential antiviral drug target, as this protein is responsible for multiple captious functions during the viral life cycle. Herein, we have investigated the potential to repurpose active antiviral compounds of plant origins for treating the SARS-CoV-2 infection. In the present study, we followed the molecular docking methodology to screen druggable natural plants’ active compounds against the nucleocapsid protein of SARS-CoV-2. The virtual screening of all 68 compounds revealed that the top seven active compounds, such as withanolide D, hypericin, silymarin, oxyacanthine, withaferin A, Acetyl aleuritolic acid, and rhein, exhibit good binding affinity with druggable ADME properties, toxicity, and Pass prediction. The stability of the docked complexes was studied by conducting molecular simulations of 100 ns. MM-GBSA calculated the binding free energy uncovered that withanolide D, hypericin, and silymarin result in highly stable binding conformations in three different sites of the nucleocapsid protein. However, further investigation is needed in order to validate the candidacy of these inhibitors for clinical trials. Highlights Natural plants’ active compounds may aid in the inhibition of SARS-CoV-2 replication and COVID-19 therapeutics. Hypericin, silymarin, withanolide D, oxyacanthine, withaferin A, Acetyl aleuritolic acid, and rhein are effective against SARS-CoV-2 N protein. Studied natural plants’ active compounds could be useful against COVID-19 and its associated organs comorbidities. ADMET properties of selected compounds favor these compounds as druggable candidates. Communicated by Ramaswamy H. Sarma. © 2022 Informa UK Limited, trading as Taylor & Francis Group.en_US
dc.language.isoenen_US
dc.publisherTaylor and Francis Ltd.en_US
dc.sourceJournal of Biomolecular Structure and Dynamicsen_US
dc.titlePlant-derived active compounds as a potential nucleocapsid protein inhibitor of SARS-CoV-2: an in-silico studyen_US
dc.typeJournal Articleen_US
Appears in Collections:Department of Biosciences and Biomedical Engineering

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: